Management of Rhinitis Medicamentosa

Primary Treatment Strategy

Immediate cessation of topical nasal decongestants combined with initiation of intranasal corticosteroids is the cornerstone of therapy; a short (5‑7 day) oral corticosteroid course may be added for severe cases to facilitate withdrawal. 1, 2

The essential first step is abrupt discontinuation of the offending topical decongestant, as continued use perpetuates rebound congestion and mucosal hyperreactivity. 1, 2
Intranasal corticosteroids should be started immediately after decongestant cessation because they are the most effective class for controlling sneezing, itching, rhinorrhea, and congestion. 3, 4
Patients should be instructed to aim the spray away from the nasal septum and to monitor for mucosal erosions; systemic side effects are minimal at recommended doses. 3, 4

A brief (5‑7 day) oral corticosteroid regimen can hasten recovery and improve tolerability of withdrawal in patients with severe rebound congestion. 1, 2
Repeated or single parenteral corticosteroid administrations should be avoided because of higher risk for long‑term adverse effects. 1
Short‑term oral decongestants (e.g., pseudo‑ephedrine or phenylephrine) may be used to provide symptomatic relief during withdrawal without reinforcing the topical decongestant cycle. 3
Blood pressure should be monitored in patients with hypertension, although significant elevation is uncommon in normotensive individuals. 3
Intranasal antihistamines can add benefit by relieving congestion and rhinorrhea, especially when a vasomotor component is present. 1, 5
These antihistamines have a rapid onset of action and produce clinically significant improvement in nasal congestion. 6

Patients must understand that even brief re‑exposure (as short as 3 days) to topical decongestants can restart the rebound cycle. 7, 3
The latency for developing rhinitis medicamentosa varies widely—from as little as 3 days to up to 4–6 weeks of continuous use. 3, 2

Gradual tapering of topical decongestants is not evidence‑based; abrupt cessation together with intranasal corticosteroids is the recommended approach. 1, 2
Nonsedating oral antihistamines should not be used as monotherapy for rhinitis medicamentosa, as they have not demonstrated efficacy in non‑allergic rhinitis conditions. 1, 5